Angiex

Developer of antibody-drug conjugates to treat cancer and cardiovascular diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups5 employees language angiex.com

Registered entities

Investor mix

7 investors on record; lead investors include Array, Presight Capital.

Investor typeCountShare
Venture capital457%
Accelerator & incubator114%
Other / undisclosed229%
Coming soon